基础医学与临床 ›› 2007, Vol. 27 ›› Issue (7): 834-840.

• 短篇综述 • 上一篇    

SELEX技术及其在医学中的应用

王岩   

  1. 医科院基础医学研究所
  • 收稿日期:2005-10-10 修回日期:2006-01-19 出版日期:2007-07-25 发布日期:2007-07-25
  • 通讯作者: 王岩

SELEX and the applications in the therapeutic fields

  • Received:2005-10-10 Revised:2006-01-19 Online:2007-07-25 Published:2007-07-25

摘要: 指数富集配基的系统进化(SELEX)技术是一类新的组合化学技术,应用人工合成的随机寡核苷酸文库,通过筛选、分离、富集获得能与各种配体特异结合的寡核苷酸适配子(Aptamer),且具有高亲和力。目前涉及多种疾病治疗的适配子,包括感染性疾病,肿瘤,心血管疾病,免疫系统疾病等已被筛选出来,并且疗效已经通过体外实验或动物模型得到证实。两个适配子已进入药物III期临床实验阶段,还有很多适配子正处于预临床实验阶段,其中部分将很快进入临床实验。本文综述了SELEX技术及寡核苷酸适配子在治疗领域的最新进展,并且对其前景进行了分析和预测。

关键词: SELEX, 适配子, 寡核苷酸, 配体, 文库

Abstract: Systematic Evolution of Ligand by Exponential enrichment (SELEX) is a new combinational chemistry methodology for in vitro selection of specific aptamers. Aptamers are artificial oligonucleotide ligands that are capable of high-affinity binding to target molecules, such as amino acids, drugs, proteins and other small molecules or ions etc. They are isolated from combinational libraries of synthetic oligonucleotide by an iterative process of affinity selection, recovery and amplification. Several properties of aptamers make them an attractive class of therapeutic compounds. Their affinity and specificity for a given protein make it possible to isolate a ligand to nearly any target, and adjusting their bioavailability expands their clinical utility. Aptamers may prove useful in the treatment of a wide variety of human diseases, including infectious illness, cancer, and cardiovascular diseases. We review the development of this emerging class of therapeutics, summarize progress to date, and speculate on the eventual utility of such agents in the clinic.

Key words: SELEX, aptamer, ligand, oligonucleotide, library